Discover how the Netherlands is Europe's quiet powerhouse in clinical innovation. With 138 trials and 31 sponsors, the Netherlands leads in life sciences.

Explore the impact of ICH E6(R3) on patient-centric clinical trials in 2026. Dive into how ICH E6(R3) reshapes trial design and patient experience.

Explore practical approaches to applying RBQM in early phase clinical trials with insights from COG UK. Learn how RBQM enhances trial efficiency.

Explore the European Health Data Space in 2026. Discover its impact on healthcare data exchange and clinical research. Learn more about the European Health Data Space in 2026.